Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-26 4:00 pm Purchase |
2024-01-24 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Medicxi Growth I LP | 7,464,572 13.000% |
4,980,298 (+200.47%) |
Filing History |
| 2023-01-31 4:00 pm Purchase |
2022-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
Medicxi Growth I LP | 19,963,157 21.100% |
1,839,265 (+10.15%) |
Filing History |
| 2023-01-31 4:00 pm Purchase |
2022-12-31 | 13G | Phathom Pharmaceuticals, Inc. PHAT |
Medicxi Growth I LP | 2,484,274 6.000% |
416,413 (+20.14%) |
Filing History |
| 2022-02-08 08:27 am Purchase |
2021-12-31 | 13G | Centessa Pharmaceuticals plc CNTA |
Medicxi Growth I LP | 18,123,892 20.160% |
18,123,892 (New Position) |
Filing History |
| 2021-11-10 3:21 pm Purchase |
2021-11-02 | 13D | Aura Biosciences, Inc. AURA |
Medicxi Growth I LP | 3,039,892 10.700% |
3,039,892 (New Position) |
Filing History |
| 2021-02-11 10:27 am Unchanged |
2020-12-31 | 13G | OBSEVA SA COM OBSVF |
Medicxi Growth I LP | 1,570,000 2.850% |
0 (Unchanged) |
Filing History |
| 2021-02-11 08:41 am Unchanged |
2020-12-31 | 13G | Merus N.V. MRUS |
Medicxi Growth I LP | 1,600,000 4.300% |
0 (Unchanged) |
Filing History |
| 2020-08-18 4:29 pm Purchase |
2020-08-11 | 13G | Checkmate Pharmaceuticals, Inc. CMPI |
Medicxi Growth I LP | 1,501,716 7.000% |
1,501,716 (New Position) |
Filing History |